World's Best Scientists 2026 revealed!
Modern Pathology
H-index 59

Modern Pathology

0893-3952

Published by: Springer

https://www.nature.com/modpathol/

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 164 588 753 58

Additional Metrics

Number of Best Scientists*: 793
Documents by Best Scientists*: 840
Top 100 Ranked Scientists*: 17
SCIMAGO H-index: 187
SCIMAGO SJR: 2.4
Impact Factor: 5.5

Overview

Top Research Topics at Modern Pathology?

The discussions in the journal mainly cover the fields of Pathology, Immunohistochemistry, Carcinoma, Internal medicine and Adenocarcinoma. While the journal focused on Pathology, it was also able to explore topics like Cancer research and Hematopathology. Staining, Antibody and In situ hybridization are some topics wherein Immunohistochemistry research discussed in the journal have an impact.

The work on Internal medicine tackled in it brings together disciplines like Gastroenterology and Oncology. Issues in Surgical pathology were discussed, taking into consideration concepts from other disciplines like Cytopathology and Anatomical pathology.

  • Pathology (95.72%)
  • Immunohistochemistry (26.56%)
  • Carcinoma (15.97%)

What are the most cited papers published in the journal?

  • PROGNOSTIC AND PREDICTIVE FACTORS IN BREAST CANCER BY IMMUNOHISTOCHEMICAL ANALYSIS (1766 citations)
  • Consensus statement on the pathology of IgG4-related disease (1570 citations)
  • Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. (873 citations)

Research areas of the most cited articles at Modern Pathology:

The published papers are organized to address concerns in the fields of Pathology, Immunohistochemistry, Carcinoma, Adenocarcinoma and Surgical pathology. The most cited papers address concerns in Pathology which are intertwined with other disciplines, such as Breast cancer, Internal medicine and Hematopathology. The study of Immunohistochemistry in the journal papers encompasses disciplines such as Cancer research, as well as fields such as Molecular biology, all of which overlap with one another.

What topics the last edition of the journal is best known for?

  • Cancer
  • Internal medicine
  • Gene

The previous edition focused in particular on these issues:

Modern Pathology focuses on Pathology, Immunohistochemistry, Internal medicine, Coronavirus disease 2019 (COVID-19) and 2019-20 coronavirus outbreak. Topics in Pathology were tackled in line with various other fields like Breast cancer and Metastasis. The studies on Immunohistochemistry discussed can also contribute to research in the domains of Fluorescence in situ hybridization and Staining.

The journal explores issues in Internal medicine which can be linked to other research areas like Gastroenterology and Oncology. The 2019-20 coronavirus outbreak research discussed is included in the broader subject of Virology. It investigates Stage (cooking) research which frequently intersects with Cancer.

The most cited articles from the last journal are:

  • Development of a prognostic model for mortality in COVID-19 infection using machine learning. (30 citations)
  • Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience. (23 citations)
  • Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia. (21 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Modern Pathology (based on the number of publications) are:

  • L. Jeffrey Medeiros (109 papers) published 10 papers at the last edition, 1 more than at the previous edition,
  • Liang Cheng (66 papers) published 6 papers at the last edition, 5 more than at the previous edition,
  • Attilio Orazi (46 papers) published 3 papers at the last edition, 2 more than at the previous edition,
  • Andrew L. Folpe (45 papers) published 9 papers at the last edition, 6 more than at the previous edition,
  • Jason L. Hornick (43 papers) published 7 papers at the last edition the same number as at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Modern Pathology (based on the number of publications) are:

  • University of Texas MD Anderson Cancer Center (323 papers) published 21 papers at the last edition the same number as at the previous edition,
  • Harvard University (292 papers) published 28 papers at the last edition, 2 less than at the previous edition,
  • Memorial Sloan Kettering Cancer Center (244 papers) published 42 papers at the last edition, 9 more than at the previous edition,
  • Mayo Clinic (237 papers) published 25 papers at the last edition, 10 more than at the previous edition,
  • Brigham and Women's Hospital (222 papers) published 29 papers at the last edition, 6 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 14.47% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 43.38% were posted by at least one author from the top 10 institutions publishing in the journal. Another 9.93% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 14.71% of all publications and 31.99% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities and Requirements in Pathology

While we delve deep into the nuances of specific research topics, it is also crucial to understand the career prospects and qualifying requirements for the aspiring professionals in these fields. For instance, taking our prime focus on Pathology and its related branches, there are varying prerequisites depending on the geographical location and specific field of work.

For a specialized career in Pathology, licensing and certification requirements often vary from state to state. Wisconsin, for instance, has specific licensure requirements for nurses who wish to practice in the field of Pathology. You can find detailed information about these requirements from the wisconsin nursing license requirements board of nursing requirements.

Pathology careers in research or academia, too, often necessitate the achievement of additional qualifications or experience in the particular area of study. It is essential to not only follow the latest research topics and trends in your chosen field but also keep an eye on the evolving career requirements and opportunities.

Through continuous education and professional development, you can stay at the forefront of your career in Pathology or any of its myriad branches. This not only enhances your professional standing but also contributes significantly towards advancements in the field.

Top Publications

  • NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls

    James P. Solomon;Irina Linkov;Andrea Rosado;Kerry Mullaney

    (2020)
    453 Citations
  • COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City.

    Alain C. Borczuk;Steven P. Salvatore;Surya V. Seshan;Sanjay S. Patel

    (2020)
    438 Citations
  • In situ detection of SARS-CoV-2 in lungs and airways of patients with COVID-19.

    Inga-Marie Schaefer;Robert F. Padera;Isaac H. Solomon;Sanjat Kanjilal;Sanjat Kanjilal

    (2020)
    267 Citations
  • SARS-CoV-2 can infect the placenta and is not associated with specific placental histopathology: a series of 19 placentas from COVID-19-positive mothers.

    Jonathon L. Hecht;Bradley Quade;Vikram Deshpande;Mari Mino-Kenudson

    (2020)
    248 Citations
  • Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience.

    Clare Bryce;Zachary Grimes;Elisabet Pujadas;Sadhna Ahuja

    (2021)
    234 Citations
  • New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.

    Kiril Trpkov;Ondrej Hes;Sean R. Williamson;Adebowale J. Adeniran

    (2021)
    179 Citations
  • Classification and reporting guidelines for the pathology diagnosis of placenta accreta spectrum (PAS) disorders: recommendations from an expert panel.

    Jonathan L. Hecht;Rebecca Baergen;Linda M. Ernst;Linda M. Ernst;Philip J. Katzman

    (2020)
    163 Citations
  • "Interchangeability" of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracy

    Emina Torlakovic;Emina Torlakovic;Hyun J. Lim;Julien Adam;Penny Barnes

    (2020)
    161 Citations
  • Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.

    Kiril Trpkov;Sean R. Williamson;Anthony J. Gill;Adebowale J. Adeniran

    (2021)
    156 Citations
  • Validation of a digital pathology system including remote review during the COVID-19 pandemic.

    Matthew G. Hanna;Victor E. Reuter;Orly Ardon;David Kim

    (2020)
    143 Citations

Related Online Degrees & Career Pathways

For those interested in expanding their medical careers beyond traditional Medicine degrees, there are various related online degrees and pathways worth exploring. Registered nurses looking to advance can consider rn to bsn online programs, which offer flexible study options often without clinical requirements, making them ideal for working professionals.

Doctors of Nursing Practice (DNP) programs present another valuable option for healthcare professionals aiming to enhance leadership and clinical skills. Some students might prioritize speed, turning to a 12 month dnp program online that condenses coursework into an accelerated time frame. Alternatively, those seeking more accessible options may prefer dnp programs designed to balance rigor with flexibility.

For individuals interested in starting healthcare careers quickly, an accelerated ma program can provide essential skills and certification in as little as six weeks, offering a fast track into the medical assistant role.

Exploring these pathways can complement a traditional Medicine degree, expanding career opportunities and specialized knowledge within the healthcare industry.

Best Scientists Contributing to This Journal

Recently Published Articles